Nanoparticles Could Deliver Hydrophobic Drugs to Macrophages
By Pritam Roy Nov 21 2022 Reviewed by Susha Cheriyedath, M.Sc.
Stay updated with breaking news from Controlled Release. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Pritam Roy Nov 21 2022 Reviewed by Susha Cheriyedath, M.Sc.
A recent study demonstrated a novel method for delivering anti-cancer drugs, conjugated to modified cell-penetrating peptides across the blood-brain barrier, in mice to treat glioblastoma.
Researchers have developed a new nanoparticle that can safely and efficiently deliver drugs direct to macrophages.
Nanotechnology-based drug delivery research has emerged as a field of interest in biomedicine that is expected to elicit therapeutic benefits.
Cancer immunotherapies, such as immune checkpoint inhibition therapy, have been attracting attention in recent years as new methods for treating cancer. However, immune checkpoint inhibition therapy is only effective in 20%–30% of cancer patients, so developing better drug delivery systems to induce anticancer cellular immunity is necessary.